Association of Serum Irisin Concentrations with Presence and Severity of Coronary Artery Disease

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2016 Nov 6

PMID 27815563

Citations 25

Authors

Wen Deng

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Irisin, an exercise-induced myokine, is closely correlated with obesity and body mass index. Obesity is one risk factor of coronary artery disease (CAD). Therefore, the present study aimed to determine if serum irisin concentrations are correlated with the presence and severity of CAD. MATERIAL AND METHODS Serum irisin concentrations were determined in 350 patients with CAD and in 214 healthy subjects. The severity of CAD was assessed by coronary atherosclerosis index (CAI). RESULTS Serum irisin concentrations were significantly lower in CAD patients compared with healthy controls. Multivariable logistic regression analysis revealed that serum irisin concentrations were an independent determinant of the presence of CAD. In addition, Pearson correlation analysis showed that serum irisin concentrations were negatively correlated with CAI in CAD patients CONCLUSIONS Decreased serum irisin concentrations may be associated with the presence and severity of CAD.

Citing Articles

Evaluation of serum irisin level and severity of erectile dysfunction in diabetic males: a cross sectional prospective study.

Ragab A, Sayed A, GamalEl Din S, Zeidan A, Ewis F, Hamed M Diabetol Metab Syndr. 2024; 16(1):233.

PMID: 39294664 PMC: 11412007. DOI: 10.1186/s13098-024-01452-3.

Swimming alleviates myocardial fibrosis of type II diabetic rats through activating miR-34a-mediated SIRT1/PGC-1α/FNDC5 signal pathway.

Guo Y, Zhou F, Fan J, Wu T, Jia S, Li J PLoS One. 2024; 19(9):e0310136.

PMID: 39250437 PMC: 11383238. DOI: 10.1371/journal.pone.0310136.

Hydrogen Sulfide and Irisin, Potential Allies in Ensuring Cardiovascular Health.

Flori L, Benedetti G, Calderone V, Testai L Antioxidants (Basel). 2024; 13(5).

PMID: 38790648 PMC: 11118251. DOI: 10.3390/antiox13050543.

Irisin and Cardiometabolic Disorders in Obesity: A Systematic Review.

Pinho-Jr J, Camacho F, Cavararo C, Baiao P, Medeiros R, Barroso S Int J Inflam. 2023; 2023:5810157.

PMID: 37900979 PMC: 10602702. DOI: 10.1155/2023/5810157.

Serum Irisin Levels Are Inversely Correlated With the Severity of Coronary Artery Disease Confirmed by Coronary Angiography: A Comparative Cross-Sectional Study.

Tanveer Y, Saif U, Lim Y Cureus. 2023; 15(7):e41475.

PMID: 37546057 PMC: 10404147. DOI: 10.7759/cureus.41475.

References

Lee M, Lee S, Nam B, Park S, Lee S, Ryu H . Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. Atherosclerosis. 2015; 242(2):476-82. DOI: 10.1016/j.atherosclerosis.2015.08.002. View

Han F, Zhang S, Hou N, Wang D, Sun X . Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. Am J Physiol Heart Circ Physiol. 2015; 309(9):H1501-8. DOI: 10.1152/ajpheart.00443.2015. View

Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y . Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2013; 63(2):514-25. DOI: 10.2337/db13-1106. View

Nikolajevic Starcevic J, Petrovic D . Carotid intima media-thickness and genes involved in lipid metabolism in diabetic patients using statins--a pathway toward personalized medicine. Cardiovasc Hematol Agents Med Chem. 2012; 11(1):3-8. DOI: 10.2174/1871525711311010003. View

Sesti G, Andreozzi F, Fiorentino T, Mannino G, Sciacqua A, Marini M . High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. 2014; 51(5):705-13. DOI: 10.1007/s00592-014-0576-0. View

Nikolajevic-Starcevic J, Pleskovic A, Santl Letonja M, Praznikar Z, Petrovic D . Polymorphisms +45T>G and +276G>T of the adiponectin gene does not affect plasma adiponectin level and carotid intima-media thickness in patients with diabetes mellitus type 2. Int Angiol. 2014; 33(5):434-40. View

Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View

Xiong X, Chen D, Sun H, Ding L, Wang J, Chen Q . FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity. Biochim Biophys Acta. 2015; 1852(9):1867-75. DOI: 10.1016/j.bbadis.2015.06.017. View

Moreno-Navarrete J, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F . Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98(4):E769-78. DOI: 10.1210/jc.2012-2749. View

10.

Lee P, Linderman J, Smith S, Brychta R, Wang J, Idelson C . Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014; 19(2):302-9. PMC: 7647184. DOI: 10.1016/j.cmet.2013.12.017. View

11.

Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J . Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis. 2015; 243(2):438-48. DOI: 10.1016/j.atherosclerosis.2015.10.020. View

12.

Polyzos S, Kountouras J, Anastasilakis A, Geladari E, Mantzoros C . Irisin in patients with nonalcoholic fatty liver disease. Metabolism. 2013; 63(2):207-17. DOI: 10.1016/j.metabol.2013.09.013. View

13.

Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F . Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol Cell Cardiol. 2015; 87:138-47. DOI: 10.1016/j.yjmcc.2015.07.015. View

14.

Gao S, Li F, Li H, Huang Y, Liu Y, Chen Y . Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes. PLoS One. 2016; 11(1):e0147480. PMC: 4723061. DOI: 10.1371/journal.pone.0147480. View

15.

Lefkowitz R, Willerson J . Prospects for cardiovascular research. JAMA. 2001; 285(5):581-7. DOI: 10.1001/jama.285.5.581. View

16.

Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T . Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation. 1981; 64(6):1174-84. DOI: 10.1161/01.cir.64.6.1174. View

17.

Wu F, Song H, Zhang Y, Zhang Y, Mu Q, Jiang M . Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway. PLoS One. 2015; 10(8):e0134662. PMC: 4524626. DOI: 10.1371/journal.pone.0134662. View

18.

Aronis K, Moreno M, Polyzos S, Moreno-Navarrete J, Ricart W, Delgado E . Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes (Lond). 2014; 39(1):156-61. DOI: 10.1038/ijo.2014.101. View